Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Pharma
Age
0–4
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pediatric patients from 1 month to less than 4 years of age
Pediatric patients diagnosed with refractory partial onset seizures, on a stable regimen of one to two other anti-epileptic drugs and at least 2 partial onset seizures per week in the two weeks prior to screening
Patients must have two partial onset seizures (with corresponding clinical event) during the 48-hour video EEG at screening
You may not be if
A ketogenic diet
Previous exposure to levetiracetam
Seizures too close together to count accurately
Treatable seizure etiology
Current diagnosis of Lennox-Gastaut Syndrome or epilepsy secondary to a progressing cerebral disease
Diagnosis of a terminal illness
Clareo Health | A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
